Jazz Pharmaceuticals To Present Data On Defibrotide, An Investigational Treatment, In Patients With Hepatic Veno-Occlusive Disease At BMT Tandem Meetings /PRNewswire/ -- Jazz Pharmaceuticals plc announced today that researchers will present data on the use of defibrotide, an investigational medicine being studied in for the treatment of hepatic veno-occlusive disease , a rare, potentially life-threatening, early complication in patients undergoing hematopoietic stem-cell transplantation therapy.
http://ift.tt/1AfSYfl
http://ift.tt/1AfSYfl
No comments:
Post a Comment